Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05934422Not ApplicableCompleted

NiPPeR Randomised Trial - Child Follow Up Study

Role: collaborator

NCT06661577Not Yet Recruiting

An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.

Role: collaborator

NCT02509988Not ApplicableCompleted

Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health

Role: collaborator

NCT02965287Completed

Validation of a Test for Fetal Malformations

Role: collaborator

All 4 trials loaded